The drug, shown to be almost as effective as opioids for short-term pain, is the first fundamentally new kind of painkiller ...
The nonaddictive painkiller suzetrigine (Journavx) is as effective for acute pain as a common opioid treatment ...
Federal officials on Thursday approved a new type of pain drug designed to eliminate the risks of addiction and overdose ...
I’m Conway Gittens reporting from the New York Stock Exchange. Here’s what we’re watching on TheStreet today. Wall Street ...
U.S. officials have approved a new type of pain drug designed to eliminate the risks of addiction and overdose associated ...
One participant in the drug trial for Journavx said it eliminated her pain without making her feel loopy or nauseous, which ...
The U.S. Food and Drug Administration approved a new non-opioid pain medication developed by the Massachusetts-based company ...
The drug represents a new pathway to treating people with pain due to surgeries or traumatic injuries, avoiding the addictive ...
Suzetrigine prevents pain signals from reaching the brain and doesn't give an opioid-like high, making it non-addictive—but ...
To help provide relief without the risk of abuse and overdoses, one pharmaceutical company is revealing its new pill designed ...